Clinical Trial Update: Platelets or Fibrinogen as First-line Treatment for Bleeding During Pedatric Heart Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating use of platelets or fibrinogen as first-line treatment for bleeding during pediatric heart surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Snippet

Sponsor: Sahlgrenska University Hospital | Conditions: Congenital Heart Disease | Phase 2 | Status: UNKNOWN